Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017.
Saved in:
Corporate Author: | |
---|---|
Format: | Government Document Electronic eBook |
Language: | English |
Published: |
Washington :
U.S. Government Publishing Office,
2018.
|
Subjects: | |
Online Access: | CONNECT |